- Home
- NBTX vs SIEB Comparison
NBTX vs SIEB Comparison
Compare NBTX & SIEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- SIEB
- Stock Information
- Founded
- NBTX 2003
- SIEB 1886
- Country
- NBTX France
- SIEB United States
- Employees
- NBTX N/A
- SIEB N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- SIEB Investment Bankers/Brokers/Service
- Sector
- NBTX Health Care
- SIEB Finance
- Exchange
- NBTX Nasdaq
- SIEB Nasdaq
- Market Cap
- NBTX 178.7M
- SIEB 148.8M
- IPO Year
- NBTX 2020
- SIEB N/A
- Fundamental
- Price
- NBTX $3.41
- SIEB $3.93
- Analyst Decision
- NBTX Strong Buy
- SIEB
- Analyst Count
- NBTX 1
- SIEB 0
- Target Price
- NBTX $8.00
- SIEB N/A
- AVG Volume (30 Days)
- NBTX 7.6K
- SIEB 60.6K
- Earning Date
- NBTX 04-02-2025
- SIEB 05-20-2025
- Dividend Yield
- NBTX N/A
- SIEB N/A
- EPS Growth
- NBTX N/A
- SIEB 57.14
- EPS
- NBTX N/A
- SIEB 0.33
- Revenue
- NBTX N/A
- SIEB $83,639,000.00
- Revenue This Year
- NBTX N/A
- SIEB N/A
- Revenue Next Year
- NBTX $221.06
- SIEB N/A
- P/E Ratio
- NBTX N/A
- SIEB $11.30
- Revenue Growth
- NBTX N/A
- SIEB 17.39
- 52 Week Low
- NBTX $2.76
- SIEB $1.41
- 52 Week High
- NBTX $7.51
- SIEB $3.85
- Technical
- Relative Strength Index (RSI)
- NBTX 55.19
- SIEB 74.21
- Support Level
- NBTX $3.26
- SIEB $3.29
- Resistance Level
- NBTX $3.65
- SIEB $3.75
- Average True Range (ATR)
- NBTX 0.19
- SIEB 0.22
- MACD
- NBTX 0.03
- SIEB 0.01
- Stochastic Oscillator
- NBTX 43.75
- SIEB 93.09
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About SIEB Siebert Financial Corp.
Siebert Financial Corp is a diversified financial services firm and provides a full range of brokerage and financial advisory services including securities brokerage, investment advisory and insurance offerings, and corporate stock plan administration solutions. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.